QT analysis: A guide for statistical programmers. Prabhakar Munkampalli Statistical Analyst II Hyderabad, 7 th September 2012

Size: px
Start display at page:

Download "QT analysis: A guide for statistical programmers. Prabhakar Munkampalli Statistical Analyst II Hyderabad, 7 th September 2012"

Transcription

1 QT analysis: A guide for statistical programmers Prabhakar Munkampalli Statistical Analyst II Hyderabad, 7 th September 2012

2 Agenda ECG ICH E14 Thorough QT/QTc study Role of Statistical Programmer References

3 Disclaimer All opinions expressed in this presentation are the author s personal views, and do not reflect the views or opinions of Novartis 3 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

4 ECG (Electrocardiogram) A test that records the electrical activity of the heart. Used to test for irregularities in how the heart functions. P WAVE: DEPOLARIZATION OF ATRIA QRS: DEPLOLARIZATION OF VENTRICLES T: REPOLARIZATION OF VENTRICLES 4 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

5 Torsades de pointes An undesirable property of some drugs is their ability to delay cardiac repolarization, an effect that can be measured as prolongation of the QT interval on the surface electrocardiogram (ECG). TdP can degenerate into ventricular fibrillation, leading to sudden death. Most drugs that have caused TdP clearly increase both the absolute QT and the QTc (hereafter called QT/QTc). 5 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

6 ECG example 6 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

7 Torsades de pointes 7 Presentation Title Presenter Name Date Subject Business Use Only

8 Torsades de pointes Documented cases of TdP (fatal and non-fatal) associated with the use of a drug have resulted in the withdrawal from the market of several drugs and relegation of other drugs to second-line status. 8 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

9 QT correction One difficultly of QT interpretation is that the QT interval gets shorter as the heart rate increases. [ QT α 1/ RR] This problem can be solved by correcting the QT time for heart rate using two formulae. Bazett correction : QTcB= QT / RR 0.5 Fridericia s correction: QTcF= QT / RR 0.33 Other correction formulae 9 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

10 ICH E14 QT analysis is necessary... Systemic bioavailability Non antiarrhythmic drugs Approved drugs with new dose or route that results in higher exposure (ie...cmax or AUC) New indication Drugs with chemical or Pharmacological class with associated with QT effect or TdP 10 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

11 Thorough QT/QTc study Not the first trial Threshold level of regulatory concern, 5 ms evidenced by the 95% confidence interval around the mean effect of 10 ms Carried out in healthy volunteers Provides guidance for later trials 11 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

12 Role of Statistical/Clinical Programmer Programmer Review of protocol and RAP Review of ecrf Planning for analysis datset Study design TLF Cross over/ Parallel 12 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

13 Inclusion / Exclusion Criterion Excluded Subjects/Patients with - A marked baseline prolongation of QT/QTc interval (e.g., repeated demonstration of a QTc interval >450 ms) A history of additional risk factors for TdP (e.g., heart failure, hypokalemia, family history of Long QT Syndrome) The use of concomitant medications that prolong the QT/QTc interval. 13 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

14 Study design of Thorough QT/QTc study Based on study objectives and PK/PD of compound. Typically Randomized, controlled trial, appropriate blinding and concurrent placebo group. Positive control group (pharmacological or nonpharmacological) to establish assay sensitivity. E.g. Moxifloxacin Crossover: Small number of subjects as individual subject acts as a control. Simples heart rate correction. Parallel : Drugs with long half lives, and when Multiple dose treatment groups to be compared. 14 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

15 Number and Timings of recordings First in human study information like Cmax, Tmax should help to estimate peak concentration of relevant analyte and plan for timing of ECG collection. Optimal timing to cover range of concentration for PK/PD analysis. Number and timings of ECG recordings depends on patient population, endpoint, statistical model, sample size, and cost effectiveness. Even though, peak serum concentration does not always correspond to the peak effect on QT/QTc interval, care should be taken to perform ECG recordings at time points around the Cmax. 15 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

16 Examples of Tables, Listings and Figures 16 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

17 17 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

18 18 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

19 Table 4 Newly occurring ECG Qualitative abnormality Abnormality Type Finding Treat. A Treat. B Treat. C N=xxx N=xxx N=xxx Total n % Total n % Total n % Any new ECG abnormality xx xx xx.x xx xx xx.x xx xx xx.x Rhythm xx xx xx.x xx xx xx.x xx xx xx.x Atrial flutter xx xx xx.x xx xx xx.x xx xx xx.x Atrial fibrillation xx xx xx.x xx xx xx.x xx xx xx.x Junctional Rhythm xx xx xx.x xx xx xx.x xx xx xx.x Morphology xx xx xx.x xx xx xx.x xx xx xx.x RAA xx xx xx.x xx xx xx.x xx xx xx.x LAA xx xx xx.x xx xx xx.x xx xx xx.x 19 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

20 20 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

21 Data collection : CRF page 21 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

22 Variables Quantitative variables Ventricular rate PR interval QRS duration QT interval Fridericia QT interval Bazett QT interval uncorrected RR interval Qualitative variables Evaluation type rhythm arrhythmia Conduction morphology MI st t waves u waves ECG interpretation 22 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

23 Checks related to source data (1) Source data: quantitative and qualitative variables in same database? 2 possibilities in the data transfer: Quantitative variables in one dataset + Qualitative variables in one dataset 2 datasets Quantitative variables + Qualitative variables in one dataset 1 dataset E.g. 1 Source ECG dataset OR Variable: ECG identification can be used to identify the duplicates in the dataset. Suggestion: Create 2 different analysis datasets to avoid duplication of information. 23 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

24 Checks related to source data (2) Source data quantitative variables: Multiple / Single measurement(s) 6 lead pre-dose measurements OR 3 lead post-dose measurements at 1.5, 3, 6 hours Average of these measurements collapsed into 1 record each Get a confirmation on the type of transfer from ECG providers If there are more number records of time-points than expected how to handle? 24 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

25 Checks related to source data (3) Source data: identification of scheduled and unscheduled visits Very important to have correct time point variable to be used later in the analysis. 25 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

26 How to report the data, some pointers: (1) Analysis dataset structure: 26 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

27 How to report the data, some pointers: (2) Various abnormality flags ECG parameter Abnormality flagging 1 QT increase of > 30 msec from baseline 2 QT increase of > 60 msec from baseline 3 QT new > 450 msec and pre-dose value <= 450 msec 4 QT new > 480 msec and pre-dose value <= 480 msec 5 QT new > 500 msec and pre-dose value <= 500 msec 6 PR < 200 msec Normal ranges 7 PR increase > 25% to a value > QRS < 110 msec Normal ranges 9 QRS increase > 25% to a value > HR bpm Normal ranges 11 RR bpm Normal ranges 12 RR + HR RR increase > 25% to HR < RR + HR RR decrease > 25% to HR > QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

28 Single(Multiple) vs. Replicate ECGs Depends on Objectives and end points. If primary objective is to estimate QTc response profile then single ECGs distributed over time is preferable. If primary objective is to estimate change in QTc at a specific point in time, replicate ECGs should reduce variability. For QT/QTc analysis, collection of multiple baseline helps to verify diurnal pattern and the QT to heart relationship for each subject in each period an provide more baseline data for individual correction. 28 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

29 Choice of baseline Time-matched (complete Day -1 profile) Account for diurnal variation in QTc May be necessary for parallel group design Single predose time point (average of triplicates) May be sufficient for crossover since time-matched comparison with placebo is within a subject 29 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

30 Analysis of QT/QTc Interval Data Both central tendency (e.g., means, medians) and categorical analyses. Provide relevant information on clinical risk assessment. In clinical trials, a prolongation of QTc > 500 ms during therapy has been a threshold of particular concern. Multiple analyses using different limits are a reasonable approach to this uncertainty, including: Absolute QTc interval prolongation: QTc interval > 450 QTc interval > 480 QTc interval > 500 Change from baseline in QTc interval: QTc interval increases from baseline > 30 QTc interval increases from baseline > QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

31 Interpretation of Thorough QT/QTc Study The results of the thorough QT/QTc study will influence the amount of information collected in later stages of development: A negative thorough QT/QTc study : Collection of on therapy ECG A positive thorough QT/QTc study : Expanded ECG safety evaluation. A negative thorough QT/QTc study but non clinical data is strongly positive: Expanded ECG safety evaluation 31 QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

32 References %2Fdiaj_11191.pdf _Q_As_R1_step4.pdf QT analysis: A guide for Statistical Programmers Prabhakar M. 7th Sep 2012 CONSPIC: JAIPUR 2012 Business Use Only

33 THANK YOU 33 Presentation Title Presenter Name Date Subject Business Use Only

Application for a Marketing Authorisation: Requirements and Criteria for the Assessment of QT Prolonging Potential

Application for a Marketing Authorisation: Requirements and Criteria for the Assessment of QT Prolonging Potential Application for a Marketing Authorisation: Requirements and Criteria for the Assessment of QT Prolonging Potential Bundesinstitut für Arzneimittel Dr. med. Clemens Mittmann Bundesinstitut für Arzneimittel

More information

Guidance for Industry

Guidance for Industry Guidance for Industry E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs U.S. Department of Health and Human Services Food and Drug Administration

More information

The Impact of Drug-Related QT Prolongation on FDA Regulatory Decisions

The Impact of Drug-Related QT Prolongation on FDA Regulatory Decisions The Impact of Drug-Related QT Prolongation on FDA Regulatory Decisions Eunjung Park, Ph.D. DBII / OGD / OPS / CDER / FDA SPS Feb 27 204 Regulatory Background Regulatory actions to QT-related cardiac proarrhythmia

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the clinical

More information

Regulatory decision-making for the assessment of ECG effects of new drugs: Exposure-response analyis

Regulatory decision-making for the assessment of ECG effects of new drugs: Exposure-response analyis Regulatory decision-making for the assessment of ECG effects of new drugs: Exposure-response analyis Kevin M. Krudys, Ph.D. Team Leader Division of Pharmacometrics Office of Clinical Pharmacology 1 Disclosures

More information

Electrocardiography Review and the Normal EKG Response to Exercise

Electrocardiography Review and the Normal EKG Response to Exercise Electrocardiography Review and the Normal EKG Response to Exercise Cardiac Anatomy Electrical Pathways in the Heart Which valves are the a-v valves? Closure of the a-v valves is associated with which heart

More information

Understanding the Electrocardiogram. David C. Kasarda M.D. FAAEM St. Luke s Hospital, Bethlehem

Understanding the Electrocardiogram. David C. Kasarda M.D. FAAEM St. Luke s Hospital, Bethlehem Understanding the Electrocardiogram David C. Kasarda M.D. FAAEM St. Luke s Hospital, Bethlehem Overview 1. History 2. Review of the conduction system 3. EKG: Electrodes and Leads 4. EKG: Waves and Intervals

More information

Equine Cardiovascular Disease

Equine Cardiovascular Disease Equine Cardiovascular Disease 3 rd most common cause of poor performance in athletic horses (after musculoskeletal and respiratory) Cardiac abnormalities are rare Clinical Signs: Poor performance/exercise

More information

NEONATAL & PEDIATRIC ECG BASICS RHYTHM INTERPRETATION

NEONATAL & PEDIATRIC ECG BASICS RHYTHM INTERPRETATION NEONATAL & PEDIATRIC ECG BASICS & RHYTHM INTERPRETATION VIKAS KOHLI MD FAAP FACC SENIOR CONSULATANT PEDIATRIC CARDIOLOGY APOLLO HOSPITAL MOB: 9891362233 ECG FAX LINE: 011-26941746 THE BASICS: GRAPH PAPER

More information

the basics Perfect Heart Institue, Piyavate Hospital

the basics Perfect Heart Institue, Piyavate Hospital ECG INTERPRETATION: the basics Damrong Sukitpunyaroj MD Damrong Sukitpunyaroj, MD Perfect Heart Institue, Piyavate Hospital Overview Conduction Pathways Systematic Interpretation Common abnormalities in

More information

Acquired, Drug-Induced Long QT Syndrome

Acquired, Drug-Induced Long QT Syndrome Acquired, Drug-Induced Long QT Syndrome A Guide for Patients and Health Care Providers Sudden Arrhythmia Death Syndromes (SADS) Foundation 508 E. South Temple, Suite 202 Salt Lake City, Utah 84102 800-STOP

More information

BASIC CARDIAC ARRHYTHMIAS Revised 10/2001

BASIC CARDIAC ARRHYTHMIAS Revised 10/2001 BASIC CARDIAC ARRHYTHMIAS Revised 10/2001 A Basic Arrhythmia course is a recommended prerequisite for ACLS. A test will be given that will require you to recognize cardiac arrest rhythms and the most common

More information

Phase of development:

Phase of development: Title of study: A randomised, placebo-controlled, double-blind, double-dummy, four-way crossover, single-centre study to investigate the effects of 2 mg and 10 mg intravenously administered NRL972 on the

More information

INTRODUCTORY GUIDE TO IDENTIFYING ECG IRREGULARITIES

INTRODUCTORY GUIDE TO IDENTIFYING ECG IRREGULARITIES INTRODUCTORY GUIDE TO IDENTIFYING ECG IRREGULARITIES NOTICE: This is an introductory guide for a user to understand basic ECG tracings and parameters. The guide will allow user to identify some of the

More information

Novartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI)

Novartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI) Novartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI) Highlights from Prescribing Information - the link to the full text PI is as follows: http://www.pharma.us.novartis.com/product/pi/pdf/gilenya.pdf

More information

HIV, High Dose Methadone, and the Treatment Conundrum 5/8/2014. Frederick L. Altice, MD, MA

HIV, High Dose Methadone, and the Treatment Conundrum 5/8/2014. Frederick L. Altice, MD, MA EXPERT PANEL Managing HIV in Special Circumstances: Patients on High-Dose Methadone Frederick L. Altice, MD, MA Professor of Medicine, Epidemiology, and Public Health Yale University HIV, High Dose Methadone,

More information

Electrocardiographic Issues in Williams Syndrome

Electrocardiographic Issues in Williams Syndrome Electrocardiographic Issues in Williams Syndrome R. Thomas Collins II, MD Assistant Professor, Pediatrics and Internal Medicine University of Arkansas for Medical Sciences Arkansas Children s Hospital

More information

The Göttingen Minipig in Cardiovascular Safety Pharmacology. August 24, 2010 We will begin at 11:00AM

The Göttingen Minipig in Cardiovascular Safety Pharmacology. August 24, 2010 We will begin at 11:00AM The Göttingen Minipig in Cardiovascular Safety Pharmacology August 24, 2010 We will begin at 11:00AM Webinar Logistics Event will be recorded and available for viewing Call in to listen via phone select

More information

Clinical Study Synopsis

Clinical Study Synopsis Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace

More information

Monitoring EKG. Evaluation copy

Monitoring EKG. Evaluation copy Monitoring EKG Computer 28 An electrocardiogram, or EKG, is a graphical recording of the electrical events occurring within the heart. A typical EKG tracing consists of five identifiable deflections. Each

More information

Sample Size Calculations for Crossover Thorough QT Studies: Non-inferiority and Assay Sensitivity

Sample Size Calculations for Crossover Thorough QT Studies: Non-inferiority and Assay Sensitivity Sample Size Calculations for Crossover Thorough QT Studies: Non-inferiority and Assay Sensitivity Suraj P. Anand, 1, Sharon C. Murray, 2 and Gary G. Koch 3 1 Department of Statistics, North Carolina State

More information

Current Management of Atrial Fibrillation DISCLOSURES. Heart Beat Anatomy. I have no financial conflicts to disclose

Current Management of Atrial Fibrillation DISCLOSURES. Heart Beat Anatomy. I have no financial conflicts to disclose Current Management of Atrial Fibrillation Mary Macklin, MSN, APRN Concord Hospital Cardiac Associates DISCLOSURES I have no financial conflicts to disclose Book Women: Fit at Fifty. A Guide to Living Long.

More information

Introduction to Electrophysiology. Wm. W. Barrington, MD, FACC University of Pittsburgh Medical Center

Introduction to Electrophysiology. Wm. W. Barrington, MD, FACC University of Pittsburgh Medical Center Introduction to Electrophysiology Wm. W. Barrington, MD, FACC University of Pittsburgh Medical Center Objectives Indications for EP Study How do we do the study Normal recordings Abnormal Recordings Limitations

More information

Sponsor. Novartis Generic Drug Name. Vildagliptin. Therapeutic Area of Trial. Type 2 diabetes. Approved Indication. Investigational.

Sponsor. Novartis Generic Drug Name. Vildagliptin. Therapeutic Area of Trial. Type 2 diabetes. Approved Indication. Investigational. Clinical Trial Results Database Page 1 Sponsor Novartis Generic Drug Name Vildagliptin Therapeutic Area of Trial Type 2 diabetes Approved Indication Investigational Study Number CLAF237A2386 Title A single-center,

More information

By the end of this continuing education module the clinician will be able to:

By the end of this continuing education module the clinician will be able to: EKG Interpretation WWW.RN.ORG Reviewed March, 2015, Expires April, 2017 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2015 RN.ORG, S.A., RN.ORG, LLC Developed

More information

Evaluation copy. Analyzing the Heart with EKG. Computer

Evaluation copy. Analyzing the Heart with EKG. Computer Analyzing the Heart with EKG Computer An electrocardiogram (ECG or EKG) is a graphical recording of the electrical events occurring within the heart. In a healthy heart there is a natural pacemaker in

More information

Interpreting a rhythm strip

Interpreting a rhythm strip 3 Interpreting a rhythm strip Just the facts In this chapter, you ll learn: the components of an ECG complex and their significance and variations techniques for calculating the rate and rhythm of an ECG

More information

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains

More information

ACLS PHARMACOLOGY 2011 Guidelines

ACLS PHARMACOLOGY 2011 Guidelines ACLS PHARMACOLOGY 2011 Guidelines ADENOSINE Narrow complex tachycardias or wide complex tachycardias that may be supraventricular in nature. It is effective in treating 90% of the reentry arrhythmias.

More information

MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question.

MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question. Exam Name MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question. 1) What term is used to refer to the process of electrical discharge and the flow of electrical

More information

Treatment for. Malaria: DHA/PQP. Science Day MMV Stakeholders Meeting. Defeating Malaria Together 1

Treatment for. Malaria: DHA/PQP. Science Day MMV Stakeholders Meeting. Defeating Malaria Together 1 ANewOnce-a-day Treatment for Uncomplicated Malaria: DHA/PQP Science Day MMV Stakeholders Meeting Dr. Ambrose Talisuna Former Director Global Access, MMV & Field Coordinator, African Eurartesim Registration

More information

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation

More information

Introduction to Electrocardiography. The Genesis and Conduction of Cardiac Rhythm

Introduction to Electrocardiography. The Genesis and Conduction of Cardiac Rhythm Introduction to Electrocardiography Munther K. Homoud, M.D. Tufts-New England Medical Center Spring 2008 The Genesis and Conduction of Cardiac Rhythm Automaticity is the cardiac cell s ability to spontaneously

More information

The P Wave: Indicator of Atrial Enlargement

The P Wave: Indicator of Atrial Enlargement Marquette University e-publications@marquette Physician Assistant Studies Faculty Research and Publications Health Sciences, College of 8-12-2010 The P Wave: Indicator of Atrial Enlargement Patrick Loftis

More information

Understanding Atrial Fibrillation/ Atrial Flutter (AF/AFL)

Understanding Atrial Fibrillation/ Atrial Flutter (AF/AFL) UNDERSTANDING AF/AFL Understanding Atrial Fibrillation/ Atrial Flutter (AF/AFL) Please see full Prescribing Information, including Boxed Warning, and Medication Guide beginning on page 7. Please see Important

More information

Fexinidazole a new oral treatment for sleeping sickness update of development

Fexinidazole a new oral treatment for sleeping sickness update of development Fexinidazole a new oral treatment for sleeping sickness update of development SMe O 2 Me CH 2 O Antoine TARRAL Olaf Valverde Séverine Blesson Clélia Bardonneau Wilfried Mutumbo September 2011 Fexinidazole

More information

Recurrent AF: Choosing the Right Medication.

Recurrent AF: Choosing the Right Medication. In the name of God Shiraz E-Medical Journal Vol. 11, No. 3, July 2010 http://semj.sums.ac.ir/vol11/jul2010/89015.htm Recurrent AF: Choosing the Right Medication. Basamad Z. * Assistant Professor, Department

More information

Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter

Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter 22 July 2010 EMA/CHMP/EWP/213056/2010 Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter Draft Agreed by Efficacy Working Party July 2008 Adoption by CHMP for release

More information

TEMPLATE DATA MANAGEMENT PLAN

TEMPLATE DATA MANAGEMENT PLAN TEMPLATE DATA MANAGEMENT PLAN ICRIN (QM sub group) Version: XX Date: XXXXXXX Page 1 of 6 1.0 Document Ownership The Data Management Plan (DMP) will be initiated and subsequently owned by the Data Manager

More information

Short Duration High-Level Exposure to Halon Substitutes: Potential Cardiovascular Effects

Short Duration High-Level Exposure to Halon Substitutes: Potential Cardiovascular Effects Short Duration High-Level Exposure to Halon Substitutes: Potential Cardiovascular Effects Halon Alternatives Technical Working Conference 1993 Reva Rubenstein, Ph.D. U.S.Environmenta1 Protection Agency

More information

A Peak at PK An Introduction to Pharmacokinetics

A Peak at PK An Introduction to Pharmacokinetics Paper IS05 A Peak at PK An Introduction to Pharmacokinetics Hannah Twitchett, Roche Products Ltd, Welwyn Garden City, UK Paul Grimsey, Roche Products Ltd, Welwyn Garden City, UK ABSTRACT The aim of this

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the clinical

More information

Systematic Approach to 12 Lead EKG Interpretation

Systematic Approach to 12 Lead EKG Interpretation Systematic Approach to 12 Lead EKG Interpretation Maureen Knechtel MPAS, PA-C Wellmont CVA Heart Institute Disclosure Statement of Financial Interest I, Maureen Knechtel, do not have a financial interest/arrangement

More information

12-Lead EKG Interpretation. Judith M. Haluka BS, RCIS, EMT-P

12-Lead EKG Interpretation. Judith M. Haluka BS, RCIS, EMT-P 12-Lead EKG Interpretation Judith M. Haluka BS, RCIS, EMT-P ECG Grid Left to Right = Time/duration Vertical measure of voltage (amplitude) Expressed in mm P-Wave Depolarization of atrial muscle Low voltage

More information

VCA Veterinary Specialty Center of Seattle

VCA Veterinary Specialty Center of Seattle An electrocardiogram (ECG) is a graph of the heart`s electrical current, which allows evaluation of heart rate, rhythm and conduction. Identification of conduction problems within the heart begins with

More information

Interpreting AV (Heart) Blocks: Breaking Down the Mystery

Interpreting AV (Heart) Blocks: Breaking Down the Mystery Interpreting AV (Heart) Blocks: Breaking Down the Mystery 2 Contact Hours Copyright 2012 by RN.com. All Rights Reserved. Reproduction and distribution of these materials is prohibited without the express

More information

How to read the ECG in athletes: distinguishing normal form abnormal

How to read the ECG in athletes: distinguishing normal form abnormal How to read the ECG in athletes: distinguishing normal form abnormal Antonio Pelliccia, MD Institute of Sport Medicine and Science www.antoniopelliccia.it Cardiac adaptations to Rowing Vagotonia Sinus

More information

TGN 1412 Welche Änderungen haben sich für die Erstanwendung am Menschen aus Sicht des BfArM ergeben?

TGN 1412 Welche Änderungen haben sich für die Erstanwendung am Menschen aus Sicht des BfArM ergeben? TGN 1412 Welche Änderungen haben sich für die Erstanwendung am Menschen aus Sicht des BfArM ergeben? PD Dr. med. Thomas Sudhop Bundesinstitut für Arzneimittel, Bonn Bundesinstitut für Arzneimittel IMP

More information

Clinical Study Synopsis for Public Disclosure

Clinical Study Synopsis for Public Disclosure abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis - which is part of the clinical

More information

Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism ERRATUM

Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism ERRATUM Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism ERRATUM This report was commissioned by the NIHR HTA Programme as project number 12/78

More information

Bios 6648: Design & conduct of clinical research

Bios 6648: Design & conduct of clinical research Bios 6648: Design & conduct of clinical research Section 1 - Specifying the study setting and objectives 1. Specifying the study setting and objectives 1.0 Background Where will we end up?: (a) The treatment

More information

QRS Complexes. Fast & Easy ECGs A Self-Paced Learning Program

QRS Complexes. Fast & Easy ECGs A Self-Paced Learning Program 6 QRS Complexes Fast & Easy ECGs A Self-Paced Learning Program Q I A ECG Waveforms Normally the heart beats in a regular, rhythmic fashion producing a P wave, QRS complex and T wave I Step 4 of ECG Analysis

More information

Basics of Pacing. Ruth Hickling, RN-BSN Tasha Conley, RN-BSN

Basics of Pacing. Ruth Hickling, RN-BSN Tasha Conley, RN-BSN Basics of Pacing Ruth Hickling, RN-BSN Tasha Conley, RN-BSN The Cardiac Conduction System Cardiac Conduction System Review Normal Conduction Conduction QRS QRS Complex Complex RR PP ST ST segment segment

More information

#AS148 - Automated ECG Analysis

#AS148 - Automated ECG Analysis BIOPAC Systems, Inc. 42 Aero Camino Goleta, Ca 93117 Ph (805)685-0066 Fax (805)685-0067 www.biopac.com info@biopac.com #AS148 - Automated ECG Analysis An electrocardiogram (ECG) is a graphical recording

More information

ARTICLE IN PRESS. Available online at www.sciencedirect.com. Received 5 November 2008

ARTICLE IN PRESS. Available online at www.sciencedirect.com. Received 5 November 2008 Available online at www.sciencedirect.com Journal of Electrocardiology xx (2009) xxx xxx www.jecgonline.com Exploring QT interval changes as a precursor to the onset of ventricular fibrillation/tachycardia

More information

Bridging Statistical Analysis Plan and ADaM Datasets and Metadata for Submission

Bridging Statistical Analysis Plan and ADaM Datasets and Metadata for Submission , October 24-26, 2012, San Francisco, USA Bridging Statistical Analysis Plan and ADaM Datasets and Metadata for Submission Abstract In this article, the relationship between the Statistical Analysis Plan

More information

Quiz 4 Arrhythmias summary statistics and question answers

Quiz 4 Arrhythmias summary statistics and question answers 1 Quiz 4 Arrhythmias summary statistics and question answers The correct answers to questions are indicated by *. All students were awarded 2 points for question #2 due to no appropriate responses for

More information

ABSTRACT INTRODUCTION PATIENT PROFILES SESUG 2012. Paper PH-07

ABSTRACT INTRODUCTION PATIENT PROFILES SESUG 2012. Paper PH-07 Paper PH-07 Developing a Complete Picture of Patient Safety in Clinical Trials Richard C. Zink, JMP Life Sciences, SAS Institute, Cary, NC, United States Russell D. Wolfinger, JMP Life Sciences, SAS Institute,

More information

HTEC 91. Topic for Today: Atrial Rhythms. NSR with PAC. Nonconducted PAC. Nonconducted PAC. Premature Atrial Contractions (PACs)

HTEC 91. Topic for Today: Atrial Rhythms. NSR with PAC. Nonconducted PAC. Nonconducted PAC. Premature Atrial Contractions (PACs) HTEC 91 Medical Office Diagnostic Tests Week 4 Topic for Today: Atrial Rhythms PACs: Premature Atrial Contractions PAT: Paroxysmal Atrial Tachycardia AF: Atrial Fibrillation Atrial Flutter Premature Atrial

More information

Statistics and Pharmacokinetics in Clinical Pharmacology Studies

Statistics and Pharmacokinetics in Clinical Pharmacology Studies Paper ST03 Statistics and Pharmacokinetics in Clinical Pharmacology Studies ABSTRACT Amy Newlands, GlaxoSmithKline, Greenford UK The aim of this presentation is to show how we use statistics and pharmacokinetics

More information

Assessment, diagnosis and specialist referral of adults (>16 years) with an episode of transient loss of consciousness (TLoC) or a blackout.

Assessment, diagnosis and specialist referral of adults (>16 years) with an episode of transient loss of consciousness (TLoC) or a blackout. Assessment, diagnosis and specialist referral of adults (>16 years) with an episode of transient loss of consciousness (TLoC) or a blackout. TLoC is common huge variation in management range of clinicians

More information

An Introduction to Tachyarrhythmias R. A. Seyon MN, NP, CCN(C) & Dr. R. G. Williams

An Introduction to Tachyarrhythmias R. A. Seyon MN, NP, CCN(C) & Dr. R. G. Williams Arrhythmias 1 An Introduction to Tachyarrhythmias R. A. Seyon MN, NP, CCN(C) & Dr. R. G. Williams Things to keep in mind when analyzing arrhythmias: Electrical activity recorded in 12 and 15 leads Examine

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S7B

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S7B INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE THE NON-CLINICAL EVALUATION OF THE POTENTIAL FOR

More information

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations & AF Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations Frequent symptom Less than 50% associated with arrhythmia

More information

Longitudinal Modeling of Lung Function in Respiratory Drug Development

Longitudinal Modeling of Lung Function in Respiratory Drug Development Longitudinal Modeling of Lung Function in Respiratory Drug Development Fredrik Öhrn, PhD Senior Clinical Pharmacometrician Quantitative Clinical Pharmacology AstraZeneca R&D Mölndal, Sweden Outline A brief

More information

An ECG Primer. Quick Look. I saw it, but I did not realize it. Elizabeth Peabody

An ECG Primer. Quick Look. I saw it, but I did not realize it. Elizabeth Peabody 4 An ECG Primer Quick Look Cardiac Monitoring System - p. 64 ECG Paper - p. 73 Lead Polarity and Vectors - p. 77 Basic ECG Components - p. 79 Heart Rate and Pulse Rate - p. 91 Summary - p. 94 Chapter Quiz

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. Current Step 4 version

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. Current Step 4 version INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE THE EXTENT OF POPULATION EXPOSURE TO ASSESS CLINICAL

More information

Wide-Complex Tachycardias in the ED: Myths and Pitfalls

Wide-Complex Tachycardias in the ED: Myths and Pitfalls Wide-Complex Tachycardias in the ED: Myths and Pitfalls, FACEP, FAAEM Professor and Vice Chair Director, Emergency Cardiology Fellowship Department of Emergency Medicine University of Maryland School of

More information

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology Atrial Fibrillation 2014 How to Treat How to Anticoagulate Allan Anderson, MD, FACC, FAHA Division of Cardiology Projection for Prevalence of Atrial Fibrillation: 5.6 Million by 2050 Projected number of

More information

Humulin (LY041001) Page 1 of 1

Humulin (LY041001) Page 1 of 1 (LY041001) These clinical study results are supplied for informational purposes only in the interests of scientific disclosure. They are not intended to substitute for the FDA-approved package insert or

More information

Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems

Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems to support collection, cleaning and management of subject

More information

Tachyarrhythmias (fast heart rhythms)

Tachyarrhythmias (fast heart rhythms) Patient information factsheet Tachyarrhythmias (fast heart rhythms) The normal electrical system of the heart The heart has its own electrical conduction system. The conduction system sends signals throughout

More information

Feature Vector Selection for Automatic Classification of ECG Arrhythmias

Feature Vector Selection for Automatic Classification of ECG Arrhythmias Feature Vector Selection for Automatic Classification of ECG Arrhythmias Ch.Venkanna 1, B. Raja Ganapathi 2 Assistant Professor, Dept. of ECE, G.V.P. College of Engineering (A), Madhurawada, A.P., India

More information

Section Four: Pulmonary Artery Waveform Interpretation

Section Four: Pulmonary Artery Waveform Interpretation Section Four: Pulmonary Artery Waveform Interpretation All hemodynamic pressures and waveforms are generated by pressure changes in the heart caused by myocardial contraction (systole) and relaxation/filling

More information

Pharmacotherapy Options in Atrial Fibrillation: Focus on Vernakalant

Pharmacotherapy Options in Atrial Fibrillation: Focus on Vernakalant REVIEW Pharmacotherapy Options in Atrial Fibrillation: Focus on Vernakalant Judy W.M. Cheng 1 and Iwona Rybak 2 1 Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences and

More information

TOP 5. The term cardiac arrhythmia encompasses all cardiac. Arrhythmias in Dogs & Cats. Sinus Arrhythmia. TOP 5 Arrhythmias Seen in Dogs & Cats

TOP 5. The term cardiac arrhythmia encompasses all cardiac. Arrhythmias in Dogs & Cats. Sinus Arrhythmia. TOP 5 Arrhythmias Seen in Dogs & Cats Top 5 ardiology Peer reviewed TOP 5 rrhythmias in Dogs & ats shley Jones, DVM mara Estrada, DVM, DVIM (ardiology) University of Florida The term cardiac arrhythmia encompasses all cardiac rhythms other

More information

Session 6 Clinical Trial Assessment Phase I Clinical Trial

Session 6 Clinical Trial Assessment Phase I Clinical Trial L1 Session 6 Clinical Trial Assessment Phase I Clinical Trial Presentation to APEC Preliminary Workshop on Review of Drug Development in Clinical Trials Celia Lourenco, PhD, Manager, Clinical Group I Office

More information

Signal-averaged electrocardiography late potentials

Signal-averaged electrocardiography late potentials SIGNAL AVERAGED ECG INTRODUCTION Signal-averaged electrocardiography (SAECG) is a special electrocardiographic technique, in which multiple electric signals from the heart are averaged to remove interference

More information

5.5 Pharmacokinetics - Sublingual

5.5 Pharmacokinetics - Sublingual 5.5 Pharmacokinetics - Sublingual 5.5.1 Single Dose Pharmacokinetics - Dose Linearity Two studies in young healthy males were dedicated to examining sublingual single rising dose (SRD) pharmacokinetics

More information

Electrolyte Physiology. Something in the way she moves

Electrolyte Physiology. Something in the way she moves Electrolyte Physiology Something in the way she moves me Electrolyte Movement CONCENTRATION GRADIENT ELECTRICAL GRADIENT DRIVING FORCE NERNST NUMBER (E-ion) CONDUCTANCE (G-ion) PERMEABILITY CHANNELS: small

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Cancer Drug and Biological Products Clinical Data in Marketing Applications U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and

More information

Electrocardiogram (ECG) as a diagnostic tool for the assessment of Cardiovascular status in alcoholics

Electrocardiogram (ECG) as a diagnostic tool for the assessment of Cardiovascular status in alcoholics Biomedical Research 2011; 22 (3): 333-337 Electrocardiogram (ECG) as a diagnostic tool for the assessment of Cardiovascular status in alcoholics Venkatesh G Department of Physiology, Sri Siddhartha Medical

More information

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent

More information

ST Segment Elevation Nothing is ever as hard (or easy) as it looks

ST Segment Elevation Nothing is ever as hard (or easy) as it looks ST Segment Elevation Nothing is ever as hard (or easy) as it looks Cameron Guild, MD Division of Cardiology University of Mississippi Medical Center February 17, 2012 Objectives 1. Describe the electrical

More information

Updated Cardiac Resynchronization Therapy Guidelines

Updated Cardiac Resynchronization Therapy Guidelines The Ohio State University Heart and Vascular Center Updated Cardiac Resynchronization Therapy Guidelines William T. Abraham, MD, FACP, FACC, FAHA, FESC Professor of Medicine, Physiology, and Cell Biology

More information

Automatic External Defibrillators

Automatic External Defibrillators Last Review Date: May 27, 2016 Number: MG.MM.DM.10dC2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

The abbreviation EKG, for electrocardiogram,

The abbreviation EKG, for electrocardiogram, CLIN PEDIATR OnlineFirst, published on January 28, 2010 as doi:10.1177/0009922809336206 Simplified Pediatric Electrocardiogram Interpretation Clinical Pediatrics Volume XX Number X Month XXXX xx-xx 2009

More information

LAST NAME VAT NUMBER. PHONE (Important for possible case discussion)

LAST NAME VAT NUMBER. PHONE (Important for possible case discussion) Long QT Panel CUSTOMER INFORMATION FIRST NAME LAST NAME ORGANIZATION VAT NUMBER BILLING ADDRESS 1ST LINE BILLING ADDRESS 2ND LINE POST CODE CITY COUNTRY EMAIL (Required) PHONE (Important for possible case

More information

GERIATRYCZNE PROBLEMY KLINICZNE/GERIATRICS MEDICAL PROBLEMS

GERIATRYCZNE PROBLEMY KLINICZNE/GERIATRICS MEDICAL PROBLEMS 65 G E R I A T R I A 2011; 5: 65-69 GERIATRYCZNE PROBLEMY KLINICZNE/GERIATRICS MEDICAL PROBLEMS Otrzymano/Submitted: 24.02.2011 Poprawiono/Corrected: 01.03.2011 Zaakceptowano/Accepted: 06.03.2011 Akademia

More information

Atrial Fibrillation Peter Santucci, MD Revised May, 2008

Atrial Fibrillation Peter Santucci, MD Revised May, 2008 Atrial Fibrillation Peter Santucci, MD Revised May, 2008 Atrial fibrillation (AF) is an irregular, disorganized rhythm characterized by a lack of organized mechanical atrial activity. The atrial rate is

More information

HEART HEALTH WEEK 3 SUPPLEMENT. A Beginner s Guide to Cardiovascular Disease HEART FAILURE. Relatively mild, symptoms with intense exercise

HEART HEALTH WEEK 3 SUPPLEMENT. A Beginner s Guide to Cardiovascular Disease HEART FAILURE. Relatively mild, symptoms with intense exercise WEEK 3 SUPPLEMENT HEART HEALTH A Beginner s Guide to Cardiovascular Disease HEART FAILURE Heart failure can be defined as the failing (insufficiency) of the heart as a mechanical pump due to either acute

More information

Electrocardiography I Laboratory

Electrocardiography I Laboratory Introduction The body relies on the heart to circulate blood throughout the body. The heart is responsible for pumping oxygenated blood from the lungs out to the body through the arteries and also circulating

More information

COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION

COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION Question: How should the EGBS Coverage Guidance regarding ablation for atrial fibrillation be applied to the Prioritized List? Question source: Evidence

More information

What is Clinical Data Management

What is Clinical Data Management What is Clinical Data Management Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications, database systems to support collection,

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) Key priorities Identification and diagnosis Treatment for persistent AF Treatment for permanent AF Antithrombotic

More information

School of Health Sciences

School of Health Sciences School of Health Sciences Cardiology Teaching Package A Beginners Guide to Normal Heart Function, Sinus Rhythm & Common Cardiac Arrhythmias Welcome This document extends subjects covered in the Cardiology

More information

Gari D. Clifford. 3.1 Introduction. 3.2 Spectral and Cross-Spectral Analysis of the ECG. CHAPTER 3 ECG Statistics, Noise, Artifacts, and Missing Data

Gari D. Clifford. 3.1 Introduction. 3.2 Spectral and Cross-Spectral Analysis of the ECG. CHAPTER 3 ECG Statistics, Noise, Artifacts, and Missing Data CHAPTER 3 ECG Statistics, Noise, Artifacts, and Missing Data Gari D. Clifford 3.1 Introduction Chapter 1 presented a description of the ECG in terms of its etiology and clinical features, and Chapter 2

More information

Danish Cardiovascular Research Academy and Faculty of Health Sciences University of Copenhagen

Danish Cardiovascular Research Academy and Faculty of Health Sciences University of Copenhagen Danish Cardiovascular Research Academy and Faculty of Health Sciences University of Copenhagen PhD course: Cardiac arrhythmias - Aim and content: Cardiac arrhythmia represents a wide spectrum of abnormalities

More information

Normal Sinus Rhythm. Sinus Bradycardia. Sinus Tachycardia. Rhythm ECG Characteristics Example (NSR) & consistent. & consistent.

Normal Sinus Rhythm. Sinus Bradycardia. Sinus Tachycardia. Rhythm ECG Characteristics Example (NSR) & consistent. & consistent. Normal Sinus Rhythm (NSR) Rate: 60-100 per minute Rhythm: R- R = P waves: Upright, similar P-R: 0.12-0.20 second & consistent P:qRs: 1P:1qRs Sinus Tachycardia Exercise Hypovolemia Medications Fever Hypoxia

More information

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG

More information